ID | Description | Gene Ratio | Bg Ratio | P value | P. adjust | q value | Gene ID | Count |
hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 6/129 | 78/8075 | 0.001484 | 0.103158 | 0.10313 | AKR1C1/AKR7A3/CBR1/CYP3A5/EPHX1/GSTM2 | 6 |
hsa00512 | Mucin type O-glycan biosynthesis | 4/129 | 32/8075 | 0.001581 | 0.103158 | 0.10313 | GALNT5/GALNT6/GALNT7/GCNT1 | 4 |
hsa05204 | Chemical carcinogenesis | 6/129 | 83/8075 | 0.002044 | 0.103158 | 0.10313 | CBR1/CYP2C18/CYP3A5/EPHX1/GSTM2/NAT1 | 6 |
hsa00480 | Glutathione metabolism | 5/129 | 57/8075 | 0.002074 | 0.103158 | 0.10313 | CHAC2/G6PD/GPX2/GSTM2/IDH1 | 5 |
hsa00514 | Other types of O-glycan biosynthesis | 4/129 | 47/8075 | 0.006522 | 0.259581 | 0.259512 | GALNT5/GALNT6/GALNT7/PLOD3 | 4 |
hsa05160 | Hepatitis C | 7/129 | 157/8075 | 0.012718 | 0.381891 | 0.38179 | CD81/CLDN1/CLDN23/IRF3/OAS1/OCLN/TLR3 | 7 |
hsa05130 | Pathogenic Escherichia coli infection | 8/129 | 197/8075 | 0.013433 | 0.381891 | 0.38179 | BAIAP2L1/CLDN1/CLDN23/IL18/ MYO5B/MYO5C/OCLN/TUBB2A | 8 |
hsa00520 | Amino sugar and nucleotide sugar metabolism | 3/129 | 48/8075 | 0.040911 | 0.926281 | 0.926036 | CYB5R3/GFPT1/GMDS | 3 |
hsa04610 | Complement and coagulation cascades | 4/129 | 85/8075 | 0.046745 | 0.926281 | 0.926036 | BDKRB1/F5/PLAU/SERPINA1 | 4 |
hsa00340 | Histidine metabolism | 2/129 | 22/8075 | 0.047501 | 0.926281 | 0.926036 | ALDH2/MAOA | 2 |